News & Updates

Electrocardiogram (ECG)- and photoplethysmography (PPG)-based wearable devices demonstrate effectiveness for paroxysmal atrial fibrillation (AF) detection following cryptogenic stroke or embolic stroke of undetermined source (ESUS) similar to that of conventional management, results of a Singapore study have shown.

In a retrospective observational study, nirmatrelvir-ritonavir trumps molnupiravir in reducing the risk of all-cause mortality at 90 days and hospitalization in COVID-19 patients with advanced kidney disease (chronic kidney disease [CKD] stage 4, ie, eGFR <30 mL/min/1.73 m2).

Smoking and occupational dust exposure appear to contribute to an increased risk of idiopathic pulmonary fibrosis (IPF), according to a study.

Potent and selective inhibition of IL-17A by izokibep produced a rapid improvement in disease activity across multiple psoriatic arthritis (PsA) domains, according to preliminary data from a phase IIb/III trial.

Upadacitinib remains effective through 5 years in patients with rheumatoid arthritis (RA) who have inadequate response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with no new safety signals, as shown by the results of the phase III long-term extension (LTE) of SELECT-NEXT.

Patients with declining kidney function following a cerebrovascular event are at increased risk of major adverse cardiovascular events (MACE), dementia, and mortality at 2 years, according to a study. However, a higher risk of death is also noted for those with a large increase in kidney function.

Findings from the phase IV INHALE-3 trial support inhaled insulin for the management of type 1 diabetes (T1D) in adults, underlining its role as an alternative insulin solution to enhance diabetes management.